Single-cell RNA-seq reveals invasive trajectory and determines cancer stem cell-related prognostic genes in pancreatic cancer

References

• Vincent A, Herman J, Schulick R, et al. Pancreatic cancer. Lancet. 2011;378:607–620.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132.
   PubMed Web of Science ®Google Scholar
• Boesch M, Sopper S, Zeimet AG, et al. Heterogeneity of cancer stem cells: rationale for targeting the stem cell niche. Biochim Biophys Acta. 2016;1866:276–289.
   PubMed Web of Science ®Google Scholar
• Bao B, Ahmad A, Azmi AS, et al. Overview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapy. Curr Protoc Pharmacol. 2013;14:14–25.
   Google Scholar
• Qiu H, Fang X, Luo Q, et al. Cancer stem cells: a potential target for cancer therapy. Cell Mol Life Sci. 2015;72:3411–3424.
   PubMed Web of Science ®Google Scholar
• Tan BT, Park CY, Ailles LE, et al. The cancer stem cell hypothesis: a work in progress. Lab Invest. 2006;86:1203–1207.
   PubMed Web of Science ®Google Scholar
• Bao Q, Zhao Y, Renner A, et al. Cancer stem cells in pancreatic cancer. Cancers (Basel). 2010;2:1629–1641.
   PubMedGoogle Scholar
• Hermann PC, Huber SL, Herrler T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 2007;1:313–323.
   PubMed Web of Science ®Google Scholar
• Ercan G, Karlitepe A, Ozpolat B. Pancreatic cancer stem cells and therapeutic approaches. Anticancer Res. 2017;37:2761–2775.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Silva L, Quevedo L, Varela I. Tumor Functional Heterogeneity Unraveled by scRNA-seq Technologies. Trends Cancer. 2020;6:13–19.
   PubMed Web of Science ®Google Scholar
• Chung W, Eum HH, Lee HO, et al. Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer. Nat Commun. 2017;8:15081.
   PubMed Web of Science ®Google Scholar
• Peng J, Sun BF, Chen CY, et al. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell Res. 2019;29:725–738.
   PubMed Web of Science ®Google Scholar
• Wang Z, Hu J, Johnson WE, et al. scruff: an R/Bioconductor package for preprocessing single-cell RNA-sequencing data. BMC Bioinformatics. 2019;20:222.
   PubMed Web of Science ®Google Scholar
• McGinnis CS, Murrow LM, Gartner ZJ. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 2019;8:329–37 e4.
   PubMed Web of Science ®Google Scholar
• Butler A, Hoffman P, Smibert P, et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36:411–420.
   PubMed Web of Science ®Google Scholar
• Becht E, McInnes L, Healy J, et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat Biotechnol. 2018.
   PubMed Web of Science ®Google Scholar
• Patel AP, Tirosh I, Trombetta JJ, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014;344:1396–1401.
   PubMed Web of Science ®Google Scholar
• Qiu X, Hill A, Packer J, et al. Single-cell mRNA quantification and differential analysis with Census. Nat Methods. 2017;14:309–315.
   PubMed Web of Science ®Google Scholar
• Duan J, Soussen C, Brie D, et al. Generalized LASSO with under-determined regularization matrices. Signal Process. 2016;127:239–246.
   PubMed Web of Science ®Google Scholar
• Choi SW, Mak TS, O’Reilly PF. Tutorial: a guide to performing polygenic risk score analyses. Nat Protoc. 2020;15:2759–2772.
   PubMed Web of Science ®Google Scholar
• Mayakonda A, Lin DC, Assenov Y, et al. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28:1747–1756.
   PubMed Web of Science ®Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139–140.
   PubMed Web of Science ®Google Scholar
• Childs EJ, Mocci E, Campa D, et al. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Nat Genet. 2015;47:911–916.
   PubMed Web of Science ®Google Scholar
• Achille A, Biasi MO, Zamboni G, et al. Chromosome 7q allelic losses in pancreatic carcinoma. Cancer Res. 1996;56:3808–3813.
   PubMed Web of Science ®Google Scholar
• Segerstolpe A, Palasantza A, Eliasson P, et al. Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes. Cell Metab. 2016;24:593–607.
   PubMed Web of Science ®Google Scholar
• Rosas PC, Nagaraja GM, Kaur P, et al. Hsp72 (HSPA1A) prevents human islet amyloid polypeptide aggregation and toxicity: a new approach for type 2 diabetes treatment. PLoS One. 2016;11:e0149409.
   PubMed Web of Science ®Google Scholar
• Cao J, Zhang Y, Yang J, et al. NEAT1 regulates pancreatic cancer cell growth, invasion and migration though mircroRNA-335-5p/c-met axis. Am J Cancer Res. 2016;6:2361–2374.
   PubMed Web of Science ®Google Scholar
• Duxbury MS, Matros E, Clancy T, et al. CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions. Ann Surg. 2005;241:491–496.
   PubMed Web of Science ®Google Scholar
• Arumugam T, Simeone DM, Van Golen K, et al. S100P promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res. 2005;11:5356–5364.
   PubMed Web of Science ®Google Scholar
• Sanford DE, Belt BA, Panni RZ, et al. Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis. Clin Cancer Res. 2013;19:3404–3415.
   PubMed Web of Science ®Google Scholar
• Fukuda A, Wang SC, Morris J, et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell. 2011;19:441–455.
   PubMed Web of Science ®Google Scholar
• Wang H-C, Hou Y-C, Shan Y. Advances in pancreatic cancer stem cells, tumor- associated macrophages, and their interplay. Cancer Cell Microenviron. 2014;1:e304.
   Google Scholar
• Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704–715.
   PubMed Web of Science ®Google Scholar
• Zhou P, Li B, Liu F, et al. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer. Mol Cancer. 2017;16:52.
   PubMed Web of Science ®Google Scholar
• Li C, Wu JJ, Hynes M, et al. c-Met is a marker of pancreatic cancer stem cells and therapeutic target. Gastroenterology. 2011;141:2218–27 e5.
   PubMed Web of Science ®Google Scholar
• Wightman SC, Uppal A, Pitroda SP, et al. Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome. Br J Cancer. 2015;113:327–335.
   PubMed Web of Science ®Google Scholar
• Mann KM, Ying H, Juan J, et al. KRAS-related proteins in pancreatic cancer. Pharmacol Ther. 2016;168:29–42.
   PubMed Web of Science ®Google Scholar